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Review of issues concerning the use of reproductive inhibitors,
with particular emphasis on resolving human-wildlife conflicts in
North America
Kathleen A. FAGERSTONE,1 Lowell A. MILLER,1 Gary KILLIAN2 and Christi A. YODER1
1

US Department of Agriculture/Animal and Plant Health Inspection Service/Wildlife Services, National Wildlife Research Center, Fort
Collins and 2Almquist Research Center, Pennsylvania State University, University Park, USA

Abstract
This manuscript provides an overview of past wildlife contraception efforts and discusses the current state of
research. Two fertility control agents, an avian reproductive inhibitor containing the active ingredient nicarbazin
and an immunocontraceptive vaccine, have received regulatory approval with the Environmental Protection Agency
and are commercially available in the USA. OvoControl G Contraceptive Bait for Canada Geese and Ovo Control for
pigeons are delivered as oral baits. An injectable immunocontraceptive vaccine (GonaCon Immunocontraceptive
Vaccine) was registered with the Environmental Protection Agency for use in female white-tailed deer in September
2009. An injectable product (GonaCon Immunocontraceptive Vaccine) is registered for use in female white-tailed
deer. Both products are labeled for use in urban/suburban areas where these species are overabundant. Several
other compounds are currently being tested for use in wildlife in the USA, Europe, Australia and New Zealand that
could have promise in the future. The development and use of reproductive inhibitors for resolving human–wildlife
conflicts will depend on a number of factors, including meeting the requirements of regulatory agencies for use in
the environment and on the biological and economical feasibility of their use. Use will also be dependent on health
and safety issues and on public acceptance of the techniques.
Key words: contraceptives, fertility control, registration, reproductive inhibitors, wildlife.

INTRODUCTION
Wild animals are valuable natural resources and vital
components of a healthy ecosystem. Wildlife provides
economic, recreational and aesthetic benefits and, to many
people, the knowledge that wildlife exists is a positive
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benefit in itself. For most of the past century, federal and
state wildlife conservation agencies in the USA and around
the world have focused on increasing populations of many
species of wildlife. In many cases, such as for the whitetailed deer Odocoileus virginianus (Zimmermann, 1780)
and Canada geese Branta canadensis (Linnaeus, 1758) in
the USA, the badger Meles meles (Linnaeus, 1758) in Great
Britain, the fox Vulpes vulpes (Linnaeus, 1758) in Europe
and the wallaby Macropus eugenii (Desmarest, 1817) in
Australia, these conservation efforts have been extremely
successful, to the point where these species are locally
overabundant and cause either ecological damage or human–wildlife conflicts, including damage to agricultural
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commodities, disease transmission to humans, livestock
or other valued wildlife, and safety issues such as wildlife
aircraft strikes. Many of the problems associated with
overabundant wildlife occur in suburban or urban areas
where regulation of wildlife populations through conventional means such as hunting, translocation or culling has
not been feasible, or is precluded because of regulations
or public perceptions. The need for wildlife management
is increasing as people continue to encroach upon natural
habitats and human–wildlife conflicts become more
frequent. At the same time, the public is becoming intolerant of perceived inhumane means of control. A growing
interest in nonlethal methods for population control of
nuisance or damaging wildlife species has fostered research
in wildlife contraception. Because fertility control acts by
reducing birth rates, rather than by increasing mortality
rates, it is perceived by the public as being more humane
and morally acceptable than conventional population control methods.
This manuscript provides an overview of issues relating to the use of contraceptive agents, particularly in North
America, as a means of resolving human–wildlife conflicts.
In the manuscript we discuss compounds currently and
previously used to control fertility in wildlife; the regulatory pathways for gaining approval of contraceptive agents
and their economic feasibility; health and safety concerns
for use of contraceptives; and public perceptions on use
of contraceptive agents. Many contentious issues have
been raised regarding the use of infertility agents for managing wildlife populations (Bomford 1990). The following
sections will address each of these issues. This paper focuses specifically on the USA, but includes references to
Europe, New Zealand and Australia, both because of collaborative research on development of wildlife contraceptives and because of new initiatives in these countries to
develop anti-fertility agents for the field control of vertebrate pests (Lapidge et al. 2007).

REVIEW OF CURRENT TECHNOLOGY
FOR WILDLIFE CONTRACEPTION
Steroids/hormones
Chemical contraception through the use of synthetic
steroids, estrogens and progestins was investigated
widely during the 1960s and 1970s in many species
(Fagerstone et al. 2002). More recently, androgens have
also been tested for use in male rodents and wolves (Canis
lupus) (Asa 1997). These steroid hormones act by interfering with ovulation or implantation of the egg in female
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animals or by impairing spermatogenesis in males.
Unfortunately, none of the steroid compounds has gone
beyond the testing stage in wildlife.
A potential use of steroids for contraception in wildlife
involves the delivery of norgestomet (a progesterone approved by the Food and Drug Administration [FDA] for
use in cattle for estrus synchronization) to black-tailed
deer (Odocoileus hemionus) using a biobullet (Jacobsen
et al. 1995; DeNicola et al. 1997a). In Jacobsen et al. (1995),
the ten treated failed to exhibit estrous behavior during
the fall rut and two treated bucks exhibited no sexual behavior for one year.
Lutalyse, produced by Upjohn (prostaglandin PGF2?),
is used in feedlot cattle during the first 100 days of gestation to interfere with pregnancy. DeNicola et al. (1997b)
and Waddell et al. (2001) reduced fertility in white-tailed
deer (Odocoileus virginianus) by injecting Lutalyse.
Levonorgestrel is the active component of the Norplant
implant approved for human use as a contraceptive implant by the FDA (McCauley & Geller 1992); it has been
used in zoos but is not effective in deer (Plotka & Seal
1989; White et al. 1994). Medroxyprogesterone acetate
(Provera) has been used in zoos. Megestrol acetate is
marketed in Europe as Ovarid and in the USA as Megace,
and Ovaban and is sometimes used as a contraceptive in
domestic dogs (Canis familiaris Linnaeus, 1758) and cats
(Felis catus Linnaeus, 1758), but it showed only weak
effects on feral cats in McDonald (1980) and no effect on
white-tailed deer in Matschke (1977). Melengestrol acetate
(MGA) is approved by the FDA for use in cattle as a daily
administration (Zimbelman & Smith 1966) for suppression
or synchronization of estrus, increased weight gain and
improved feed efficiency (Bennett 1993). It has been shown
to inhibit reproduction in white-tailed deer when ingested
daily (Roughton 1979) or implanted (Bell & Peterle 1975;
Plotka & Seal 1989). MGA implants have been used by
zoos for approximately 20 years, but recent findings of
uterine pathology in felids have raised concerns about its
use (Kazensky et al. 1998).
Some steroid hormones target males rather than females
(Asa 1997). Bisdiamine is a compound that selectively interferes with spermatogenesis but not testosterone
production. When administered in ground meat daily to
gray wolves it suppressed spermatogenesis without affecting mating behavior (Asa et al. 1996). Indenopyridine
also blocks sperm production; it has been tested in rodents and dogs (Chang et al. 2002). Alpha-chlorohydrin
(Epibloc), a male chemosterilant, was approved by the
Environmental Protection Agency (EPA) for use as a rat
control agent in 1982 (Bowerman & Brooks 1971; Ericsson
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1982; Andrews & Belknap 1983) but is no longer marketed.
At low doses it caused temporary sterilization, with time
to recovery of fertility dependent on dose. A single high
dose caused permanent sterility but showed toxic effects.
In addition, rats (Rattus spp.) have a promiscuous mating
system, so targeting only male rats offered little promise
as a population control technique.
Despite considerable effort, steroid hormones have not
been used successfully to inhibit reproduction in overabundant animals. Although steroids can be fed orally or
implanted, they are effective for only a short period and
need repetitive applications, making them costly and impractical in most field situations. Some steroids, such as
diethylstilbestrol (DES), persist in tissue and in the food
chain, making them unsatisfactory from an environmental
point of view. They can also have deleterious health effects on treated animals. For example, DES was found to
be a teratogen when given to pregnant women.

Chemicals that cause premature ovarian
failure (senescence)
In most species of mammals, the female is born with a
finite number of primordial follicles. The number of follicles that are ovulated is small compared with the total
number of primordial follicles present at birth; most follicles do not develop fully, but undergo atresia (cell death)
at various development stages. Follicular atresia occurs
continuously in the ovary after birth until the supply of
follicles is depleted and ovarian failure (menopause in
women) or sterilization occurs. Scientists are currently
looking into techniques that will induce early ovarian failure as a tool for reproductive control of pest animals.
One chemical that has been shown to destroy oocytes
contained in primordial and primary follicles is 4vinylcyclohexene diepoxide (VCD). The compound 4vinylcyclohexene (VCH) is used in the synthesis of rubber products, insecticides, flame retardants, antioxidants
and plasticizers. In vivo, VCH is metabolized to VCD by
cytochrome P450-catalyzed epoxidation (Hu et al. 2006).
Medical researchers investigating the mechanisms of premature ovarian failure and menopause use VCD to induce
these conditions in rodent models. Repeated exposure to
VCD selectively destroys primordial and primary follicles
by increasing the rate of follicular atresia, ultimately depleting the ovary of most of the existing follicles and causing ovarian senescence (Mayer et al. 2004; Hue et al. 2006).
This leads to a hormonal profile comparable to a female in
menopause, characterized by high luteinizing hormone (LH)
and follicle stimulating hormone (FSH) concentrations and
decreased estradiol concentrations.
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Mayer et al. (2004) report that repeated exposure of
VCD depletes small pre-antral (primordial and primary)
ovarian follicles, resulting in follicle depletion and ovarian
failure. Ten days of VCD treatment appears to be the minimum number of days required to initiate ovotoxic effects;
approximately half the follicle supply is depleted after 15
days of treatment, and almost all follicles are depleted after 30 days of treatment (Springer et al. 1996; Mayer et al.
2004; Hu et al. 2006). This compound could, therefore, be
used as a permanent sterilant for selected wildlife species
when given in repeated doses. Mayer (2006) has begun
looking at VCD as an injectable contraceptive for use in
dogs (C. familiarus) and cats (Felis domesticus).

Avian contraceptives
Interfering with egg laying or the hatchability of the
egg can be used to reduce reproductive capacity in birds.
Egg addling, including shaking or oiling the eggs in the
nest, effectively reduces egg hatchability (Pochop et al.
1998). Egg oiling with corn oil is allowed by the EPA under
the Federal Insecticide, Fungicide and Rodenticide Act
(Revised October 1988) 25b exemption for natural
products, and is being used to reduce reproduction in
Canada geese (B. canadensis) and gulls (Larus spp.).
However, this method is labor intensive and probably
useful only in small areas.
Ornitrol (DiazaCon) is a cholesterol mimic that has a
chemical structure similar to cholesterol (Miller &
Fagerstone 2000). It inhibits formation of pregnenolone,
the parent compound of steroid hormones, preventing
formation of testosterone and progesterone. DiazaCon
persists in the body, so its reproductive inhibition effects
can last up to several months. It was registered in the late
1960s with the EPA as the oral pigeon (Columba livia
Gmelin, 1789) reproductive inhibitor Ornitrol, but the registration was cancelled in 1993. Although the drug was
effective in reducing egg laying and egg hatchability
(Woulfe 1968), the pigeon is a year-round breeder and
long-term use of the compound became expensive. In
addition, long-term ingestion of this product at high levels might have undesirable health effects on the birds
(Lofts et al. 1968) because cholesterol is necessary for a
range of key processes within the body as well as the
production of reproductive hormones. In recent tests, the
compound was found to be effective in reducing egg laying,
egg fertility and egg hatchability for 2–4 months in coturnix
quail Coturnix coturnix (Linnaeus, 1758) after feeding it
for 10–14 days (Yoder 2000; Yoder et al. 2004). It was effective on both sexes, with testosterone declining in treated
males and progesterone declining in treated females (Yoder
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et al. 2004). DiazaCon might prove useful in controlling
the reproduction of seasonally breeding bird species when
fed just prior to breeding in the spring. It is being tested in
the monk parakeet Myiopsitta monachus (Boddaert, 1783)
in Florida, where the birds nest on power stations and
power poles, causing power outages (Avery et al. 2006).
DiazaCon is not species-specific, and could potentially be
effective in mammalian as well as avian species.
Conjugated linoleic acid (CLA) has been tested as an
avian infertility agent for use in cold climates. It is used as
a feed additive to increase weight gain and feed efficiency
in broiler chickens (Chin et al. 1994). When fed to laying
chickens, CLA reduces hatchability by causing solidification of the yolk at refrigerator temperatures (Cooney 1995).
In theory, when the clutch is being laid in the spring, the
bird does not incubate the nest until the clutch is complete.
As the temperature drops during the night, the yolk of
unincubated eggs from CLA-fed birds solidifies, interfering with hatchability. CLA is specific to avian species and
its effect is reversible but it needs to be fed for 10 or more
days. In a study by Aydin & Cook (2006), CLA increased
embryonic mortality in pigeon eggs to 100% after 10 weeks
of feeding. However, it was ineffective in a limited field
trial with Canada geese (S. Craven, University of
Wisconsin, personal communication).
Nicarbazin (NCZ) is a compound approved by the FDA
for control of coccidiosis in broiler chickens; if accidentally fed to breeder or layer hens, NCZ causes reduction in
hatchability and egg laying due to increased permeability
of the membrane between the egg white and egg yolk,
which destroys the conditions necessary for development
of the embryo (Jones et al. 1990). The ideal dose rate allows the female bird to lay eggs and sit on them, but prevents hatching. Advantages of nicarbazin are that it is
specific to egg layers, it is cleared from the body within
approximately 48 h and the infertility effect is reversible. A
disadvantage of the compound is that it has to be fed
continuously prior to and during egg laying. Nicarbazin
was tested by the National Wildlife Research Center
(NWRC) and subsequently registered by Innolytics LLC
as a reproductive inhibitor for use in Canada geese in 2005
and for use in pigeons in 2007. Field studies show that use
of Ovocontrol G immediately prior to and during the breeding season can reduce numbers and hatchability of eggs
laid by Canada geese, thereby reducing recruitment of
goslings into problem resident populations (Bynum et al.
2005, 2007)

Immunocontraception vaccines
Much recent research has gone into the development
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of immunocontraceptive vaccines, which use the animal’s
immune system to produce antibodies against gamete
proteins, reproductive hormones and other proteins essential for reproduction. The antibodies interfere with the
biological activity of the reproductive agents (Talwar &
Gaur 1987); the vaccines can be effective for 1–4 years or
longer (Turner & Kirkpatrick 1991; Miller et al. 2000b).
Zona pellucida vaccines

The zona pellucida (ZP) is a glycoprotein layer located
on the outer surface of the egg. Antibodies to ZP result in
infertility either by blocking sperm from penetrating the
ZP layer or by interfering with egg maturation within the
follicle (Dunbar & Schwoebel 1988). The porcine ZP (PZP)
vaccine includes both the PZP protein from the pig ovary
and an adjuvant (an additive to increase the immune
response). PZP has been successfully tested in numerous
species, including dogs (Mahi-Brown et al. 1985), baboons
(Dunbar 1989), coyotes (Canis latrans) (Miller 1995;
DeLiberto et al. 1998; Miller et al. 2006), burros (Equus
asinus) (Turner et al. 1996), wild horses (Equus caballus)
(Kirkpatrick et al. 1990; Garrott et al. 1992; Turner et al.
2000, 2002, 2007; Killian et al. 2004, 2006b) and whitetailed deer (Turner et al. 1992, 1997; Miller et al. 2000a,b,
2001; Fraker et al. 2002; Miller & Killian 2002). PZP is not
effective in cats (Jewgenow et al. 2000) or rodents (Drell
et al. 1984). Injecting with an initial and a booster dose of
PZP vaccine has caused infertility in deer and horses for
several years (Miller et al. 2000b). A vaccine (SpayVac)
developed by ImmunoVaccine Technologies and using an
adjuvant developed at the National Wildlife Research Center (Adjuvac) has been effective in white-tailed deer and
horses for up to four years after a single shot (Fraker et al.
2002; Killian et al. 2004, 2006b). The single-shot is a major
breakthrough because animals only need to be handled
once. PZP vaccines are not species-specific and are effective in reducing fertility in most mammals tested. A disadvantage of PZP in deer is that it is associated with multiple
estrous cycles in does, which could result in late season
births if antibody titers drop below a critical threshold late
in the breeding season.
Immunocontraception with gonadotropin-releasing
hormone vaccines

Gonadotropin-releasing hormone (GnRH)
immunocontraceptive vaccines take advantage of the role
played by GnRH in regulating mammalian reproduction.
GnRH controls steroidogenesis and gametogenesis by
stimulating the release of gonadotropins from the pituitary,
triggering the cascade of reproductive hormones that lead
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to ovulation. An immunocontraceptive vaccine developed
by the United States Department of Agriculture’s (USDA)
NWRC shows great potential as a contraceptive agent for
deer and other mammals. GonaCon Immunocontraceptive
Vaccine (NWRC, Fort Collins, Colorado, USA) can be administered as a single injection that suppresses reproduction in treated animals of both sexes (Miller et al. 2004b).
GonaCon Vaccine causes immunization against GnRH by
stimulating the production of antibodies that neutralize
GnRH in the vasculature between the hypothalamus and
the anterior pituitary gland (Adams & Adams 1992; Herbert
& Trigg 2005). As a result, secretion of LH and FSH by the
anterior pituitary is suppressed. In females, follicular
development, ovulation and estrus are inhibited. In males,
testosterone levels are reduced; testicular size and aggressive behavior decrease significantly, and no interest
is shown in estrous females (Miller et al. 2004b). As long
as antibody titers to native GnRH are sufficiently elevated,
reproductive behavior will be suppressed and the contraceptive effect will last in both sexes (Miller et al. 2004b).
GonaCon has induced contraception in many mammalian
species, including California ground squirrels
(Spermophilus beecheyi) (Nash et al. 2004), captive Norway rats (Rattus norvegicus) (Miller et al. 1997), domestic
cats (F. catus) (Levy et al. 2004), domestic and feral swine
(Sus scrofa) (Killian et al. 2003, 2006c; Miller et al. 2003),
wild horses (Equus caballus) (Killian et al. 2004, 2006a),
bison (Bison bison) (Miller et al. 2004a) and white-tailed
deer (Miller et al. 2000).
Gonadotropin-releasing hormone is a small hormone
that is a weak antigen due to its low molecular weight and
its being a “self” hormone (Herbert & Trigg 2005). GnRH
is made immunogenic by conjugating it to a large, nonself, hemocyanin protein harvested from marine mollusks
(Miller et al. 2003, 2004b). An adjuvant is used in conjunction with the vaccine to achieve an immune response sufficient to provide contraception. The adjuvant used in
GonaCon vaccine was developed at NWRC and consists
of a modified USDA-approved vaccine for Johne’s disease called Mycopar (Fort Dodge Animal Health, Fort
Dodge, Iowa, USA). Mycopar is approved for use in food
animals and, therefore, does not raise concerns regarding
the consumption of GonaCon-treated deer by humans or
by other non-target species (Miller et al. 2004b).
The USDA submitted an application to the US EPA in
January of 2008 for registration of GonaCon as a contraceptive agent for adult female white-tailed deer. GonaCon
was approved for registration in September 2009 as a “Restricted Use” product, for use by USDA Wildlife Services
or state wildlife management agency personnel or persons
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working under their authority. GonaCon users will also
need to follow state authorization processes.
Sperm antibody vaccines

Sperm vaccines could potentially disrupt fertility in females as well as in males. Sperm head glycoproteins that
bind to ZP have been identified. If these glycoproteins are
used as vaccines, antibodies are produced in the female
and are available to bind to sperm present in the oviduct,
preventing conception by blocking the sperm from binding to the ZP surrounding the egg. Sperm protein
immunocontraception is being investigated for contraception in the red fox (Vulpes vulpes), rabbit (Oryctolagus
cunniculs) and tammar wallaby (Macropus eugenii) in
Australia (Tyndale-Biscoe 1991; Morell 1993; Bradley 1997;
Asquith et al. 2006). Although not yet tested in wildlife
species, contraceptive vaccines targeting sperm DNA being evaluated in laboratory rodents show some promise
for future development of a sperm directed vaccine
(Jagadish et al. 2006; Naz 2006).

Gonadotropin-releasing hormone agonist
Superactive analogs of the GnRH hormone (agonists),
such as leuprolide, have been synthesized that are many
times more active than naturally occurring GnRH and act
to suppress the release of reproductive hormones. Longterm treatment with a GnRH agonist has been shown to
prevent ovulation by decreasing GnRH receptors on
gonadotropes, reducing receptor sensitivity to GnRH,
decreasing pituitary LH content and by suppressing pulsatile secretion of LH and FSH (Nett et al. 1981; Aspden et
al. 1996; D’Occhio et al. 1996). These conditions persist
as long as the agonist is present, but once treatments are
terminated, normal ovarian function is restored (Bergfeld
et al. 1996). Continuous treatment with a GnRH agonist
inhibits ovulation in females of several species, including
dogs, cattle, sheep, horses, monkeys, deer and elk (Cervus
elaphus) (see Fagerstone et al. 2002). Agonists of GnRH
have been used in domestic ungulates for controlling ovarian activity, gonadal steroidogeneis and reproduction
(D’Occhio et al. 2002). However, their use in wild ungulates has been limited (Becker & Kautz 1995; Brown &
Jochle 2001), as a result, in part, to the need for continuous delivery of a therapeutic dose for the duration of the
desired period of infertility. Recently, the impracticality of
this approach for wildlife applications has been largely
overcome by the development of long-acting biodegradable implants that can deliver a sustained release of GnRH
agonist over a predetermined period of time (Ravivarapu
et al. 2000; Trigg & Doyle 2001). Controlled release, GnRH
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agonist formulation (ATRIGEL, Atrix Laboratories, Fort
Collins, Colorado, USA) has been shown to effectively
suppress reproductive function in captive and free-ranging elk, and captive mule deer (O. hemionus) for one breeding season, without significant physiological or behavioral side effects (Baker et al. 2002, 2003, 2004). Results of
recent experiments with captive elk indicate that this
leuprolide formulation is equally effective in suppressing
reproduction when administered either subcutaneously
or with a syringe dart, thus enhancing the efficacy of management applications (Baker et al. 2005).

Gonadotropin releasing hormone: toxin
conjugate
For wild ungulates, a single-dose long-acting contraceptive offers a promising technology for population management (Hobbs et al. 2000). A new contraceptive approach
being studied involves linking synthetic analogs of GnRH
to cytotoxins. By coupling a superactive analog of GnRH
to a cytotoxin, it is possible to specifically target that toxin
to LH-secreting and FSH-secreting cells in the anterior
pituitary gland, potentially inducing permanent sterility in
both sexes. Preliminary results in female mule deer indicate that a GnRH-toxin conjugate will suppress LH secretion for up to 6 months (Baker et al. 1999).
There are a number of complex technical, biological,
economic and legal issues that need to be addressed before any of the reproductive inhibitors discussed above
can be used widely in field situations. One of the most
important of those considerations is whether the reproductive inhibitors can be approved for use by regulatory
agencies.

REGULATION OF WILDLIFE
CONTRACEPTION DRUGS, WITH
EMPHASIS ON THE USA
Environmental protection agencies throughout the
world are encouraging the replacement of persistent or
unpopular vertebrate pesticides with more humane alternative toxicants or nonlethal means of control (Eason et
al. 2010). In particular, the USA, New Zealand and Australia are undertaking collaborative research and new initiatives to develop more humane and species-targeted toxins and anti-fertility agents for the field control of vertebrate pests (Lapidge et al. 2007). The agencies responsible for the regulation of reproductive inhibitors for wildlife include the Australian Pesticide and Veterinary Medicine Authority, the Environmental Risk Management Au-
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thority in New Zealand and the EPA in the USA. Calls
have been made for greater collaboration and harmonization in the registration of pesticides and, in particular, for
vertebrate pesticides in these countries (Lapidge et al.
2007). However, because the USA currently has the only
registered reproductive inhibitors for wildlife, this review
will focus on the regulatory process in the USA. Between
1996 and 2006, the regulatory agency responsible for wildlife contraceptives in the USA was the FDA, Center for
Veterinary Medicine (CVM). Working under this premise,
the NWRC progressed toward fulfilling the FDA’s regulatory requirements by obtaining Investigational New Animal Drug (INAD) numbers for several contraceptives;
these INADs allowed research to be conducted on field
efficacy and target animal safety. During this time, it became clear that wildlife contraceptives were incompatible
with the FDA’s regulatory process. In response, the FDA
and the EPA negotiated an agreement on contraceptive
uses. Beginning in 2006, the EPA assumed regulatory authority over contraceptives used for wildlife and feral
animals. The CVM will retain authority over all uses in
captive animals, including livestock, companion animals
and zoo animals.
The EPA is responsible for regulating pesticides under
the Federal Insecticide, Fungicide and Rodenticide Act.
Registration of a contraceptive “pesticide” by the EPA
requires submission of a series of studies on product
chemistry, toxicity, non-target hazards, environmental fate
and efficacy. The EPA registration process can take several years. The EPA has fewer registration requirements
for an injectable immunocontraceptive vaccine than for
an oral product because an injectable product poses little
risk of negative impact to air, water and soil, or to nontarget animals. There are currently two fertility control
agents for wildlife that have received approval by the EPA.
OvoControl G, an orally-delivered product, was recently
registered by Innolytics, LLC (working cooperatively with
the NWRC), for managing Canada geese and pigeons and
is commercially available in the USA. USDA/Animal and
Plant Health Inspection Service received a registration for
the single-shot GonaCon Immunocontraceptive Vaccine
in September, 2009 for managing white-tailed deer in areas
where traditional management techniques, such as sport
hunting, cannot be employed.
The two contraceptive “pesticides” currently registered
are considered restricted use products and may be used
only by certified pesticide applicators. The certified applicator legend has been required for several reasons: (i)
training may be necessary to ensure the humane treatment of the animals (i.e. knowledge of darting, trapping
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Table 1 Estimated relative efficiency of reproductive and lethal control based on numbers remaining after three years from an initially
stable population of 1000 individuals in which reproductive or survival rate is reduced annually by 50% (using population models
presented in Dolbeer 1998)

†
Efficiency ratios presented are specific to population status after three years and will increase during additional years of treatment. ‡Survival
reduced 50% for age classes > 0. §Survival reduced 50% for age classes > 1. ¶Survival and reproduction of adults (>3 months old) reduced three
times per year. ††Survival and reproduction of adults (>3 months old) reduced once per year.

and other capture methods); (ii) there may be a potential
hazard to the person administering some products if they
are not handled properly; and (iii) the restriction minimizes
potential for inappropriate use or non-target hazards. Because wildlife are owned by the public in the USA and
managed by federal and/or state wildlife agencies, these
agencies need to be consulted regarding use.

BIOLOGICAL AND ECONOMIC
FEASIBILITY OF CONTRACEPTIVES
In addition to regulatory requirements, an important
consideration for development of reproductive inhibitors
is the practicality of their use for free-ranging wildlife.
Whether fertility control is biologically feasible or economically advantageous when compared to lethal control
for a particular species and population depends on a number of parameters (Curtis et al. 1997; Nielsen et al. 1997),
including whether the population is “open” or “closed,”
population numbers, sex ratios, age structure and esti-
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mated rate of increase and mortality of the concerned
species. Dolbeer (1998) uses population models to compare the relative efficiency (i.e. percentage decline in population size relative to number of animals sterilized or
removed) of reproductive control and lethal control in
managing wildlife populations. The predicted relative efficiencies of lethal and reproductive control for various wildlife species (Table 1) can be generalized based on adult
survival rate and age at which animals reproduce. Whether
lethal control is more efficient than contraception depends
on the age at first reproduction in combination with the
adult survival rate. For animals that first breed at one or
two years of age, lethal control is only more efficient than
contraception for reducing populations when adult survival rates exceed 0.56 and 0.23, respectively. However,
for animals that first breed at three years of age, lethal
control will always be more efficient than contraception
for reducing populations, regardless of the adult survival
rate (Dolbeer 1998). In general, this means that reproductive control will be most effective in managing species
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such as rodents or some bird species with high reproductive rates and low survival rates. Knipling and McGuire’s
(1972) theoretical model demonstrates that if 70% of rats
can be sterilized for three generations (one year), the population will be almost eliminated, whereas a similar effort
using lethal control allows the population to rebound to
its original size. Reproductive control will typically be less
efficient than lethal control in managing populations for
larger species such as deer, coyotes and Canada geese
that do not typically reproduce until 2–4 years of age and
have smaller litter or clutch sizes than most rodents and
small birds. Therefore, for long-lived wildlife species like
deer, it may be prudent to reduce the population herd to a
desired number by some other management technique
before applying fertility control to stabilize herd growth
(Nielsen et al. 1997).
Hobbs et al. (2000) produce a series of models examining fertility control of ungulates and conclude that >50%
of fertile females need to be maintained infertile to achieve
reductions in ungulate numbers. When adult survival is
high (>95%), Hobbs et al. assume that 60% of breeding
females need to be infertile to achieve a population
reduction. Garrott (1995) and McCullough (1996) also estimate that 60–80% of adult females would require effective annual contraceptive treatment to stabilize populations with a yearly (rather than a longer-lasting) treatment.
Seagle and Close (1996) suggest that sterilization of <50%
of does would maintain population size over a 30-year
period, whereas it would take 5–10 years to see a significant population decline with sterilization of >50% of does
in a closed population. Merrill et al. (2006) determine that
in a closed population, permanent fertility control could
begin to reduce a population after 2–3 years, and a population reduction of approximately 60% could be achieved
within 10 years if approximately 30–45% of the animals
were captured annually. Hobbs et al. (2000) note that fertility control using long-lived agents could be more efficient than culling in regulating ungulate numbers, and that
when contraception persists for the lifetime of the animal,
models predict that, in most cases, the effort required to
regulate a population at a specified density using fertility
control would be less than the effort required for culling.

Economic practicality
In addition to being biologically feasible, infertility
agents will need to be economically practical to use. Economic practicality involves the cost of development and
authorization of the contraceptive, as well as costs of
treatment, including labor, equipment and contraceptive.
Field use of contraceptives can be costly. Development
of single-shot GnRH and PZP immunocontraception vac-
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cines has made their use more economically and logistically feasible than when multiple shots of vaccines were
required; however, vaccines are injectable only by hand
or using a biobullet or dart gun. Capture and injection by
hand is preferred because animals can be individually
marked when they are injected. Costs to capture and inject deer have been estimated to be greater than $250 for
each deer marked (Curtis et al. 1997). Hobbs et al. (2000)
state that the expense of fertility control will not compete
favorably with the revenue that could be provided by licensed hunters. They suggest that the greatest efficiency
can be obtained by combining initial culling with contraceptive treatment using multi-year fertility control agents.
Oral delivery would be a practical, cost-effective means to
deliver contraceptive vaccines to some populations of freeroaming animals (Miller 1997). However, oral delivery of
vaccines is a difficult technology and is not expected to
be developed soon.
Chemical contraceptives such as steroids, DiazaCon
and nicarbazin (OvoControl G), can be delivered orally in
baits but it can be difficult to get adequate bait
consumption. For example, OvoControl G (used to reduce
egg hatchability) must be fed to Canada geese daily for
the entire egg laying period. DiazaCon also must be fed to
animals several times over a 10–14 day period. These compounds must also be used over multiple years to reduce
populations.

HEALTH AND SAFETY ISSUES
When the reproductive inhibitors discussed previously
are used for long periods of time or are placed out into the
environment, their use raises questions regarding the
health and safety of: (i) target animals; (ii) non-target
animals; and (iii) humans. Fagerstone et al. (2002) summarize the potential health effects of contraceptive agents.
Health data on target animals have been gathered for the
immunocontraceptive products PZP and GnRH. In longterm studies involving PZP and GnRH on white-tailed deer
(Miller et al. 2000b,c; Miller & Killian 2000), animals were
observed for effects on reproduction, behavior and animal health. GnRH vaccine treatments of white-tailed deer
led to reduced progesterone concentrations, altered estrus behavior, contraception, failure to maintain pregnancy
following conception, and reduced fawning rates (Miller
et al. 2000). Infertility lasted up to two years without a
booster injection. GnRH-immunized bucks demonstrated
no sexual activity when paired with control does. Depending on the immunization schedule, antlers either dropped
early or remained in velvet. Necropsies of recently vaccinated deer showed that ovaries looked normal.
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A comprehensive study of toxicity and safety of use of
GonCon was conducted (Killian et al. 2006c) as part of the
package required by the EPA to register GonCon for use in
white-tailed deer. In the 20-week study, some does were
given a single injection of GonCon and some were given
three injections of GonaCon at two-week intervals per
dose. Blood was assayed for LH, testosterone, progesterone and anti-GnRH titers. In addition, hematology and
blood chemistry were checked, and the general health of
each doe was observed. At week 20, deer were killed and
evaluated at necropsy by veterinary pathologists, and
samples of tissues were taken for histology. There were
no significant contraindications or toxic effects associated with GonaCon.
Data on health and behavioral effects related to PZP
(Fagerstone et al. 2002) are available from both limited
field applications (Turner et al. 1997; Warren et al. 1997;
McShea et al. 1997) and from long-term studies (Miller et
al. 2000c, 2001). A nine-year study of PZP-injected deer at
Pennsylvania State University showed that vaccinated
deer returned to fertility within 4–7 years after vaccinations ceased (Miller et al. 2000c). A long-term blood chemistry survey study on PZP-immunized deer found no statistically significant health changes in vaccinated deer
(Miller et al. 2001). Over a four-year period, the health of
control and treated deer were compared using measurements of body weight, serum cholesterol and blood serum
chemistry profiles. No significant differences were found,
suggesting that the health of the PZP-treated deer was
not affected by long-term immunocontraceptive treatment
(Miller et al. 2001). However, the PZP vaccine has been
shown to increase the number of times a doe comes into
estrus (estrus was occasionally extended into February
for white-tailed deer), thereby prolonging the breeding
season and potentially resulting in late summer or autumn
births (Killian & Miller 2000; Miller & Killian 2000). In
Northern climates, fawns are typically born in spring and
early summer, grow rapidly during the summer and accumulate fat reserves to draw upon during the winter when
sources of adequate nutrition are minimal. Smaller late
fawns lack sufficient time to prepare adequately for winter
and, consequently, have a poorer body condition, reduced
ability to deal with snow and colder temperatures and reduced ability to evade predators.
Nicarbazin has been used by the poultry industry in
numerous countries for 45 years. It has no effects in mammal species and is safe for both target and non-target bird
species, even when administered at much higher doses
than needed to cause the contraceptive effect (Wildlife
Services 2004; Bynum et al. 2005). DiazaCon, as a choles-
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terol inhibitor, could cause health effects in either target
or non-target species if fed for extended periods (Sachs &
Wolfmann 1965; Yoder et al. 2004). Trials with target species to establish appropriate dosages need to be conducted
to minimize the risk of birds receiving a toxic dose.
In addition to being safe for target animals, contraceptives should not have adverse effects on non-target
animals. Because technology is not currently available to
make infertility agents species-specific, delivery systems
should be developed to limit effects on non-target species.
Delivery mechanisms such as injection, darting or implanting require direct contact with animals and will not affect
non-target species. Use of oral bait delivery systems offers a way to treat larger, free-roaming populations at lower
cost, but there is increased risk of unintentional treatment
of non-target species. Therefore, the delivery system for
contraceptive baits should be designed to exclude most
non-targets. For example, an elevated bait station could
be designed to allow a white-tailed deer doe to feed but
exclude some non-target species.
Contraceptives used on huntable species of wildlife
pose an additional safety consideration: safety to humans
who may consume them. This risk is addressed by regulatory requirements of approval for drugs or pesticides. For
compounds that accumulate in body tissue and could have
secondary effects, such as some of the steroid
contraceptives, FDA or EPA approval would not be granted
for use in food animals such as deer and Canada geese
without adequate data on chemical withdrawal times.
Immunocontraception vaccines provide few risks for consumptive use of dosed wildlife; the antibodies that prevent reproduction are only one of millions of other antibodies present in animals, all of which are harmless to the
organism that digests them, like any other proteinaceous
food consisting of amino acids. Two infertility agents being researched for birds (nicarbazin and CLA) are already
authorized by the FDA for use in broiler chickens and
have low risk to humans. The third compound potentially
proposed for birds, DiazaCon, was initially designed to be
given to humans to lower serum cholesterol levels and,
therefore, should present minimal hazard for human consumption at levels that would be potentially present in
animal tissues.

PUBLIC ATTITUDES TOWARDS
WILDLIFE FERTILITY CONTROL
AGENTS
In addition to the biological, economic and legal issues
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that have to be considered before wildlife fertility agents
can be used in field situations, these fertility agents need
to be socially acceptable for that particular use.
Traditionally, hunting, trapping or toxicants have been
the primary management tools for controlling wildlife
populations. In the USA, hunting has been the most important tool for managing most overabundant game
populations. Many wildlife agencies and biologists have
been reluctant to acknowledge the potential applicability
of fertility control for managing wildlife populations
(Warren 1995), in part because contraceptives have been
publicized as replacements for sport hunting. A survey of
134 state, regional and national agencies and organizations in the USA (Sanborn et al. 1994) found that only 9%
of state wildlife agencies had an established policy on
wildlife contraception, compared to 39% of 54 environmental and animal activist groups.
In large, free-ranging game populations, traditional
methods of population reduction will still need to be applied because the cost and difficulty of delivery of contraceptive techniques would preclude their use. However,
during the past 20 years, as farmlands and open habitats
have been converted to suburban land uses, changes in
wildlife distributions and density have increased the frequency of human–wildlife interactions in urban–suburban areas and parks where public hunting or trapping are
not permitted by law. Local residents often experience
conflicts with wildlife; many of these residents are opposed to lethal control of wildlife and support the development and use of nonlethal techniques such as
contraception. Wildlife management agencies must be responsive to these suburban/urban stakeholders as well
as to traditional ones. Achieving effective, humane and
environmentally sensitive management of wildlife is of
increasing concern to conservation biologists, wildlife
managers, policy-makers and the general public. Therefore,
researchers are seeking alternative means to manage
wildlife, including use of contraceptives, and wildlife management agencies might be forced by the public to consider the costs and benefits of using contraception for
managing wildlife populations.
Toxicants and trapping have always been relied upon
heavily to control populations of non-native wildlife, such
as the brush-tail possum (Trichosurus vulpecula) in New
Zealand, the red fox in Australia and Germany, and the
gray squirrel (Sciurus carolinensis) in Great Britain and
Italy.
Surveys have shown that the public, particularly urban–suburban dwellers, are receptive to wildlife control
in general and to the use of reproductive inhibitors in
particular (Barr et al. 2002; Konig 2008). Although lethal
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control methods are currently used most frequently for
controlling non-native wildlife, the public is increasingly
more amenable to nonlethal control measures, such as livetrapping and contraception (Barr et al. 2002), and there is
increasing public antipathy towards lethal methods of
control. An example is the grey squirrel, which was introduced to Britain from North America in the late 1800s
(Middleton 1930). Gray squirrels compete with native red
squirrels (Sciurus vulgaris) and have replaced them
throughout much of Britain (Barr et al. 2002). Despite their
negative impact on red squirrel populations, gray squirrels are generally well liked by the public, who enjoy watching them. Toxicants are not publicly acceptable and translocation is not an option because, as an introduced species,
gray squirrels may not be released after trapping. Contraception offers a potential nonlethal option for reducing
the rate of spread of the gray squirrel.
Although currently available contraceptive techniques
can sometimes be uneconomical for practical
implementation, even in small localized populations of
game species such as deer, they can be combined effectively with other management techniques in an integrated
pest management approach. In these instances, a practical use for contraceptive products would be to maintain a
wildlife population at a desired level after reduction of the
population by other means.

SUMMARY
Currently, two oral contraceptive products (Ovocontrol
G for use to manage resident Canada geese, and
Ovocontrol P to manage pigeons) are available for commercial use in the USA. In addition, the injectable
immunocontraceptive GonaCon has been registered in the
USA for use in white-tailed deer. Other chemicals and vaccines are in various stages of development and testing by
various agencies and organizations in the USA, Europe,
Australia, New Zealand and elsewhere.
There are several factors that will determine when and
where contraceptives will be useful for managing overabundant wildlife. The biological feasibility of using contraceptives to manage wildlife populations depends on
the age at first reproduction and the adult survival rate.
For animals that first breed at one or two years of age,
either contraception or lethal control can be more efficient
depending on the adult survival rate. However, for animals that first breed at three years of age, lethal control
will be more efficient than contraception for reducing
populations, regardless of the adult survival rate. This
means that reproductive control will be most effective in
managing species such as rodents or some bird species
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with high reproductive rates and low survival rates. For
long-lived wildlife species like deer, it may be prudent to
reduce the population herd to a desired number by some
other management technique before applying fertility control to stabilize herd growth.
In addition to being biologically feasible, infertility
agents will need to be economically practical. The cost of
development and authorization of the contraceptive, as
well as costs of treatment, including labor, equipment and
contraceptive must be taken into account. Contraceptives
also need to be evaluated for health effects: are they safe
for the target animals, for non-target animals, and for
humans? The regulatory agencies that register contraceptives for use play a large role in ensuring that wildlife and
human health and safety are considered. In addition, because currently available infertility agents are not species-specific, delivery systems need to be developed to
limit effects on non-target species. Delivery mechanisms
such as injection require direct contact with animals and
will not affect non-target species, but use of oral bait delivery systems should be designed to exclude most nontargets. Contraceptives used on huntable species of wildlife pose a potential safety risk to humans who may consume them. All of the currently registered contraceptives
have been thoroughly evaluated by the appropriate regulatory agency and have been found to pose minimal risk
to target or non-target species, humans or to the
environment.
The public is increasingly requesting the use of nonlethal techniques when managing wildlife, including
contraceptives, and communities are sometimes willing to
fund reproductive control of wildlife populations. Wildlife
agencies and biologists have been reluctant to acknowledge the potential applicability of fertility control for managing wildlife populations, in part because fertility control
has been publicized as a replacement for sport hunting. In
reality, neither the cost nor efficiency of delivery for contraceptive techniques would allow their use on free-ranging game populations outside urban areas. However, wildlife management agencies are increasingly willing to view
fertility control as an alternative to other management tools
for non-game species and for game species in areas where
hunting is restricted. The challenges for wildlife managers
will be to integrate contraceptive technologies with more
conventional methods of wildlife population management.
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